Veradermics Statistics

Total Valuation

Veradermics has a market cap or net worth of $4.22 billion. The enterprise value is $3.83 billion.

Market Cap	4.22B
Enterprise Value	3.83B

Important Dates

The last earnings date was Tuesday, May 12, 2026, before market open.

Earnings Date	May 12, 2026
Ex-Dividend Date	n/a

Share Statistics

Veradermics has 41.78 million shares outstanding. The number of shares has increased by 746.32% in one year.

Current Share Class	41.78M
Shares Outstanding	41.78M
Shares Change (YoY)	+746.32%
Shares Change (QoQ)	+2,928.18%
Owned by Insiders (%)	8.01%
Owned by Institutions (%)	51.42%
Float	27.21M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	9.65
P/TBV Ratio	10.79
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 59.12

Current Ratio	59.12
Quick Ratio	58.43
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-22.86%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$4.70M
Employee Count	21
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	84.46
200-Day Moving Average	n/a
Relative Strength Index (RSI)	54.71
Average Volume (20 Days)	562,786

Short Selling Information

The latest short interest is 2.06 million, so 4.93% of the outstanding shares have been sold short.

Short Interest	2.06M
Short Previous Month	2.32M
Short % of Shares Out	4.93%
Short % of Float	7.57%
Short Ratio (days to cover)	3.04

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-89.29M
Pretax Income	-84.83M
Net Income	-98.80M
EBITDA	n/a
EBIT	-89.29M
Earnings Per Share (EPS)	-$15.84

Full Income Statement

Balance Sheet

The company has $390.80 million in cash and n/a in debt, with a net cash position of $390.80 million or $9.35 per share.

Cash & Cash Equivalents	390.80M
Total Debt	n/a
Net Cash	390.80M
Net Cash Per Share	$9.35
Equity (Book Value)	390.64M
Book Value Per Share	10.46
Working Capital	390.35M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$79.45 million and capital expenditures -$5,000, giving a free cash flow of -$79.46 million.

Operating Cash Flow	-79.45M
Capital Expenditures	-5,000
Depreciation & Amortization	n/a
Net Borrowing	n/a
Free Cash Flow	-79.46M
FCF Per Share	-$1.90

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Veradermics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-746.32%
Shareholder Yield	-746.32%
Earnings Yield	-2.34%
FCF Yield	-1.88%

Analyst Forecast

The average price target for Veradermics is $131.00, which is 29.82% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$131.00
Price Target Difference	29.82%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2